1.Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
Dong Myung KIM ; Kyungmi YANG ; Beom Seok YANG
Experimental & Molecular Medicine 2003;35(5):421-430
CDK2 and CDK4 known promoter of cell cycling catalyze phosphorylation of RB protein. Enzyme specificity between two CDKs that work at a different cell cycle phase is not clearly understood. In order to define kinase properties of CDK2 and CDK4 in complex with cycline A or cycline D1 in relation to their respective role in cell cycling regulation, we examined enzymatic properties of both CDK4/cycline D1 and CDK2/cycline A in vitro. Association constant, Km for ATP in CDK4/cyclin D1 was found as 418 micrometer, a value unusually high whereas CDK2/cyclin A was 23 micrometer, a value close to most of other regulatory protein kinases. Turnover value for both CDK4/cyclin D1 and CDK2/cyclin A were estimated as 3.4 and 3.9 min(-1)respectively. Kinetic efficiency estimation indicates far over one order magnitude less efficiency for CDK4/cyclin D1 than the value of CDK2/cycline A (9.3 pM(-1)min(-1)and 170 pM(-1)min(-1)respectively). In addition, inhibition of cellular CDK4 caused increase of cellular levels of ATP, even though inhibition of CDK2 did not change it noticeably. These data suggest cellular CDK4/cyclin D1 activity is tightly associated with cellular ATP concentration. Also, analysis of phosphorylated serine/threonine sites on RB catalyzed by CDK4/cyclin D1 and CDK2/cyclin A showed significant differences in their preference of phosphorylation sites in RB C-terminal domain. Since RB is known to regulate various cellular proteins by binding and this binding is controlled by its phosphorylation, these data shown here clearly indicate significant difference in their biochemical properties between CDK4/cyclin D1 and CDK2/cyclin A affecting regulation of cellular RB function.
Adenosine Triphosphate/metabolism
;
Amino Acid Sequence
;
Baculoviridae/genetics
;
CDC2-CDC28 Kinases/genetics/isolation&purification/*metabolism
;
Cyclin A/genetics/isolation&purification/*metabolism
;
Cyclin D1/genetics/isolation&purification/*metabolism
;
Cyclin-Dependent Kinases/antagonists&inhibitors/genetics/isolation&purification/*metabolism
;
Human
;
Kinetics
;
Molecular Sequence Data
;
Phosphorylation
;
Protein Conformation
;
Protein p16/metabolism
;
Recombinant Proteins/genetics/isolation&purification/metabolism
2.Total triterpenoids from Ganoderma Lucidum suppresses prostate cancer cell growth by inducing growth arrest and apoptosis.
Tao WANG ; Zi-ping XIE ; Zhan-sen HUANG ; Hao LI ; An-yang WEI ; Jin-ming DI ; Heng-jun XIAO ; Zhi-gang ZHANG ; Liu-hong CAI ; Xin TAO ; Tao QI ; Di-ling CHEN ; Jun CHEN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(5):736-741
In this study, one immortalized human normal prostatic epithelial cell line (BPH) and four human prostate cancer cell lines (LNCaP, 22Rv1, PC-3, and DU-145) were treated with Ganoderma Lucidum triterpenoids (GLT) at different doses and for different time periods. Cell viability, apoptosis, and cell cycle were analyzed using flow cytometry and chemical assays. Gene expression and binding to DNA were assessed using real-time PCR and Western blotting. It was found that GLT dose-dependently inhibited prostate cancer cell growth through induction of apoptosis and cell cycle arrest at G1 phase. GLT-induced apoptosis was due to activation of Caspases-9 and -3 and turning on the downstream apoptotic events. GLT-induced cell cycle arrest (mainly G1 arrest) was due to up-regulation of p21 expression at the early time and down-regulation of cyclin-dependent kinase 4 (CDK4) and E2F1 expression at the late time. These findings demonstrate that GLT suppresses prostate cancer cell growth by inducing growth arrest and apoptosis, which might suggest that GLT or Ganoderma Lucidum could be used as a potential therapeutic drug for prostate cancer.
Antineoplastic Agents, Phytogenic
;
isolation & purification
;
pharmacology
;
Apoptosis
;
drug effects
;
Caspase 3
;
genetics
;
metabolism
;
Caspase 9
;
genetics
;
metabolism
;
Cell Line, Tumor
;
Cell Survival
;
drug effects
;
Cyclin D1
;
genetics
;
metabolism
;
Cyclin-Dependent Kinase 4
;
genetics
;
metabolism
;
Cyclin-Dependent Kinase Inhibitor p21
;
genetics
;
metabolism
;
Dose-Response Relationship, Drug
;
E2F1 Transcription Factor
;
genetics
;
metabolism
;
G1 Phase Cell Cycle Checkpoints
;
drug effects
;
genetics
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Male
;
Nucleosomes
;
drug effects
;
metabolism
;
pathology
;
Plant Extracts
;
chemistry
;
Prostate
;
drug effects
;
metabolism
;
pathology
;
Reishi
;
chemistry
;
Signal Transduction
;
Triterpenes
;
isolation & purification
;
pharmacology